Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

Clinical test predicts best rheumatoid arthritis treatment on first try

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can strike quickly at any age—but ...

Arthritis & Rheumatism

Protein target could control chronic inflammation without affecting acute response

Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or ...

Arthritis & Rheumatism

The many ways that AI enters rheumatology

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The ...

Arthritis & Rheumatism

Osteoarthritis: Too many non-evidence-based therapies?

Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life. EULAR—The European Alliance of Associations for Rheumatology—has developed recommendations and ...

Arthritis & Rheumatism

Exploring patient experiences in juvenile idiopathic arthritis

Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist into adulthood. Two new works presented at the 2025 congress of EULAR—The European Alliance of ...

Arthritis & Rheumatism

Study reveals risk factors for spinal deterioration in r-axSpA

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic musculoskeletal disease that predominantly affects the axial skeleton. axSpA is an umbrella term that comprises the whole spectrum of patients with and without ...

Arthritis & Rheumatism

The value of physical activity for people with RMD

Regular physical activity is increasingly promoted for people with rheumatic and musculoskeletal diseases (RMD) as well as the general population. EULAR—The European Alliance of Associations for Rheumatology—has published ...

Arthritis & Rheumatism

Patient organizations: Supporting RMD patients with education

When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all at once, while others may prefer to receive it in smaller portions or like to spread it out. This ...

Arthritis & Rheumatism

Guidance needed for RMD patients seeking help online

Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of ...

Arthritis & Rheumatism

First data from the EULAR RheumaFacts project

Rheumatic and musculoskeletal diseases (RMD) are the leading causes of disability worldwide, resulting in significant health care and social support costs. One of the reasons for this increasing burden seems to be the variability ...

Arthritis & Rheumatism

Studies identify predictors and outcomes in systemic sclerosis

The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold capillaroscopy, and specific autoantibodies in patients with Raynaud's phenomenon as a very early disease ...

Arthritis & Rheumatism

Have arthritis? Design your office to ease the strain

Whether your job is remote or takes you to an office, you'll feel better and offset joint pain by having a workspace that's designed to work for you instead of against you.

Arthritis & Rheumatism

How to rewind the clock on arthritic cartilage

A new study in Aging Cell describes how a key protein called Signal Transducer and Activator of Transcription 3 (STAT3) might turn back the clock on aging cartilage that leads to osteoarthritis.

Medical research

Researchers uncover new cell types involved in osteoarthritis

A Michigan Medicine study has identified a new potential target for treating osteoarthritis—a debilitating joint disease that affects over 31 million Americans and is a leading cause of disability worldwide.

Arthritis & Rheumatism

Rheumatologist recommends patients receive pneumococcal vaccine

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against ...

Medications

New drug offers hope for people with hand osteoarthritis

A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in ...

Arthritis & Rheumatism

New AI can detect early osteoarthritis from X-ray images

Researchers from the University of Jyväskylä and the Central Finland Health Care District have developed an AI-based neural network to detect an early knee osteoarthritis from X-ray images. AI was able to match doctors' ...

Arthritis & Rheumatism

Updated: Giant cell arteritis classification criteria

Giant cell arteritis is the most common form of systemic vasculitis in people over the age of 50. It affects large‐ and medium‐sized blood vessels, particularly in the head—although not exclusively. Common symptoms ...

Diseases, Conditions, Syndromes

Classification criteria established for Takayasu arteritis

Takayasu arteritis is a type of large‐vessel vasculitis that affects the aorta—the main artery that carries blood away from the heart. This damage can cause complications such as stroke, heart attacks, and pain in the ...